We wonder why there are billing concerns and prior authorization requirements with insurance companies for genetic or genomic testing that patients truly deserve and, when appropriate, changes outcomes substantially in patient care? Why would these organizations put...
Recently, under the banner of “access”, a trade association that represents a number of biomarker testing laboratories sent a letter to two Medicare administrators expressing concerns about the administrators’ proposals for tightening coverage on precision oncology...
“In one of the largest genetic testing fraud cases ever tried to verdict, today’s sentence makes clear that the Department will seek justice for those who put profits above patient care, including owners and executives,” said Acting Assistant Attorney General Nicole...
Many DTC (Direct-to-Consumer) tests use a polygenic risk score (PRS) to ESTIMATE that individuals potential disease risk. The LACK of regulation in the Laboratory Developed Testing (LDT) also extends into a market that targets consumers for “wellness”...
Recent Comments